| 000 | 01213nam a2200325 c 4500 | ||
|---|---|---|---|
| 999 |
_c83708 _d83708 |
||
| 001 | 83708 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102111952.0 | ||
| 008 | 160825r20002011xxu 001 0 eng d | ||
| 020 | _a9780198501008 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRS403 _b.S28 2011 |
|
| 080 | _a615.32 | ||
| 100 | 1 |
_aSaunders, John _d1947- _922533 _0comprobar BNE19900351537 |
|
| 245 | 1 | 0 |
_aTop drugs : _btop synthetic routes _cJohn Saunders |
| 250 | _areprinted 2011 | ||
| 260 |
_aOxford _aNueva York _bOxford University Press _c2011 |
||
| 300 |
_a90 páginas _c25 cm |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_asin mediación _bn _2rdamedia |
||
| 338 |
_avolumen _bnc _2rdacarrier |
||
| 490 | 0 |
_aOxford chemistry primers _v90 |
|
| 650 | 7 |
_aQuímica farmacéutica _0comprobar BNE19901004645 _2embne _9141808 |
|
| 901 | _ai9780198501008 | ||
| 907 |
_a.b1292703x _b10-11-17 _c18-07-16 |
||
| 942 |
_2lcc _cMSA |
||
| 945 |
_aRS403 .S28 2011 _g1 _i9301275293 _j0 _lmcg _o- _pEUR0.00 _q- _r- _so _t2 _u0 _v0 _w0 _x0 _y.i11224575 _z25-08-16 |
||
| 945 |
_aRS403 .S28 2011 _g2 _i9301275239 _j0 _lmcg _o- _pEUR0.00 _q- _r- _s- _t1 _u1 _v10 _w1 _x0 _y.i11224587 _z25-08-16 |
||
| 998 |
_am _a_vill _b25-08-16 _cm _da _ea _feng _gxxu _h0 |
||